| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 46 |
| 1 | METHOTREXATE SODIUM | 41 |
| 2 | ETANERCEPT | 39 |
| 3 | METHOTREXATE | 37 |
| 4 | LAMIVUDINE | 33 |
| 5 | OMEPRAZOLE MAGNESIUM | 32 |
| 6 | LAMIVUDINE ORAL | 29 |
| 7 | ATORVASTATIN CALCIUM | 28 |
| 8 | METFORMIN | 27 |
| 9 | OMEPRAZOLE | 26 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CETIRIZINE 10MG | 1 | 0.1667 |
| 1 | TRIMIPRAMINE MALEATE | 4 | 0.0101 |
| 2 | DIETHYLPROPION HYDROCHLORIDE | 1 | 0.0078 |
| 3 | NITROFURANTOIN (MACROCRYSTALS) | 2 | 0.0032 |
| 4 | TERLIPRESSIN | 1 | 0.0030 |
| 5 | FLURANDRENOLIDE | 1 | 0.0030 |
| 6 | VANDETANIB | 4 | 0.0022 |
| 7 | BETAXOLOL HYDROCHLORIDE | 1 | 0.0019 |
| 8 | OXYMETAZOLINE HCL | 1 | 0.0018 |
| 9 | FACTOR IX COMPLEX | 2 | 0.0017 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vasopressin Receptor Agonist [EPC] | 1 | 0.0030 |
| 1 | CCR5 Co-receptor Antagonist [EPC] | 3 | 0.0013 |
| 2 | Dopamine-2 Receptor Antagonist [EPC] | 10 | 0.0013 |
| 3 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 4 | Type I Interferon Receptor Antagonist [EPC] | 2 | 0.0010 |
| 5 | Tyrosine Kinase 2 Inhibitor [EPC] | 3 | 0.0010 |
| 6 | Macrolide Antibacterial [EPC] | 1 | 0.0010 |
| 7 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 42 | 0.0009 |
| 8 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 63 | 0.0006 |
| 9 | Interferon alfa-2b [EPC] | 1 | 0.0005 |